Bedal raises €10 million in latest funding round, driven by patented fixation system

When Bedal developed its catheter fixation system, the company addressed a clear clinical need: a solution that allows patients and healthcare professionals to secure catheters safely and effectively. This innovation, marketed under the name FlexGRIP®, formed the basis for a strong patent portfolio developed in collaboration with Arnold & Siedsma.

The strategic use of patent protection played a central role in Bedal’s growth. The patented fixation system was key to attracting investment. In its first funding round, the company raised €500,000, followed by €2.6 million in a second round. Most recently, Bedal closed a new capital round worth €10 million.

The patented technology not only provided investors with added security but also convinced hospitals of the clinical value of the product. As a result, Bedal rapidly expanded its commercial presence and now works with more than 40 distributors across the United States, the Middle East, and Asia. The company is well on its way to becoming a market leader in its segment.

In the coming period, Bedal will focus on developing new applications for pediatric and neonatal patients. These innovations are expected to lead to new products and patents, further strengthening the company’s strategic position.

Discover more here: www.flex-grip.com